1
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis
Condition(s):Plaque PsoriasisLast Updated:June 14, 2021Withdrawn
Halobetasol Propionate: 26 Clinical Trials, Page 1 of 3
Hide Studies Not Open or Pending
2
Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%
Condition(s):Plaque PsoriasisLast Updated:September 16, 2020Terminated
3
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
Condition(s):Palmoplantar Psoriasis; Plaque PsoriasisLast Updated:April 20, 2021Recruiting
4
Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis
Condition(s):PsoriasisLast Updated:September 2, 2010Completed
5
Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects
Condition(s):HealthyLast Updated:August 17, 2010Completed
6
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
Condition(s):Atopic DermatitisLast Updated:September 25, 2019Terminated
7
The Dose-response Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects
Condition(s):HealthyLast Updated:August 17, 2010Completed
8
Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis
Condition(s):Plaque PsoriasisLast Updated:January 18, 2020Completed
9
Comparing the Efficacy of Ultravate Ointment in Combination With Lac-Hydrin Lotion in the Treatment of Psoriasis
Condition(s):Stable Plaque PsoriasisLast Updated:January 4, 2019Completed
10
Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments
Condition(s):HealthyLast Updated:October 15, 2021Completed